Related Experiment Video
Updated: May 9, 2026
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Impaired D-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy
Katharina Klatte1, Timo Kirschstein, David Otte
1Laboratory of Experimental Epileptology, Department of Epileptology and Institute of Molecular Psychiatry, University of Bonn, D-53127 Bonn, Germany.
Summary
Reduced d-serine levels in epilepsy impair NMDA receptor (NMDAR) function, affecting memory. Supplementing d-serine can restore NMDAR function and improve spatial learning in epileptic rats.
Area of Science:
- Neuroscience
- Neurochemistry
- Epilepsy Research
Background:
- Synaptic plasticity, crucial for learning and memory, is modulated by NMDA receptors (NMDARs).
- NMDAR activation requires a coagonist, typically d-serine in the forebrain.
- Experimental epilepsy in rats is linked to altered NMDAR function.
Purpose of the Study:
- To investigate the role of d-serine in the NMDAR dysfunction observed in experimental epilepsy.
- To determine if d-serine deficiency contributes to memory deficits in epilepsy.
- To explore the therapeutic potential of d-serine for epilepsy-associated cognitive impairment.
Main Methods:
- Induction of experimental epilepsy in a rat model.
- Measurement of central nervous system (CNS) d-serine levels.
- Assessment of NMDAR coagonist binding site saturation.
- Analysis of synaptic NMDAR subunit composition.
- Electrophysiological recordings of hippocampal long-term potentiation (LTP).
- Behavioral testing of spatial learning in epileptic rats.
Main Results:
- Epilepsy induced a significant reduction in CNS d-serine levels.
- This reduction led to desaturation of coagonist binding sites on synaptic and extrasynaptic NMDARs.
- Changes in synaptic NMDAR subunit composition were observed in chronic epilepsy.
- NMDAR desaturation resulted in impaired hippocampal LTP, which was reversed by exogenous d-serine.
- Administration of exogenous d-serine improved spatial learning in epileptic rats.
Conclusions:
- D-serine deficiency is a key factor contributing to memory impairments in temporal lobe epilepsy.
- Restoring d-serine levels can rescue NMDAR function and ameliorate cognitive deficits.
- D-serine holds potential as a therapeutic agent for managing amnestic symptoms in epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...